These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16210393)

  • 21. Cotinine selectively activates a subpopulation of alpha3/alpha6beta2 nicotinic receptors in monkey striatum.
    O'Leary K; Parameswaran N; McIntosh JM; Quik M
    J Pharmacol Exp Ther; 2008 May; 325(2):646-54. PubMed ID: 18305015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subunit composition of nicotinic receptors in monkey striatum: effect of treatments with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine or L-DOPA.
    Quik M; Vailati S; Bordia T; Kulak JM; Fan H; McIntosh JM; Clementi F; Gotti C
    Mol Pharmacol; 2005 Jan; 67(1):32-41. PubMed ID: 15470079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subsynaptic localization of nicotinic acetylcholine receptor subunits: a comparative study in the mouse and rat striatum.
    Garção P; Oliveira CR; Cunha RA; Agostinho P
    Neurosci Lett; 2014 Apr; 566():106-10. PubMed ID: 24607281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of nigrostriatal alpha 6-containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by beta 3 subunit gene deletion.
    Gotti C; Moretti M; Clementi F; Riganti L; McIntosh JM; Collins AC; Marks MJ; Whiteaker P
    Mol Pharmacol; 2005 Jun; 67(6):2007-15. PubMed ID: 15749993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. α4 nicotinic acetylcholine receptor modulated by galantamine on nigrostriatal terminals regulates dopamine receptor-mediated rotational behavior.
    Inden M; Takata K; Yanagisawa D; Ashihara E; Tooyama I; Shimohama S; Kitamura Y
    Neurochem Int; 2016 Mar; 94():74-81. PubMed ID: 26911419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of AN317, a novel selective agonist of α6β2-containing nicotinic acetylcholine receptors.
    Sandager-Nielsen K; Ahring PK; Klein J; van Hout M; Thaneshwaran S; Dos Santos AB; Jacobsen TA; Amrutkar DV; Peters D; Jensen AA; Kohlmeier KA; Christophersen P; Dyhring T
    Biochem Pharmacol; 2020 Apr; 174():113786. PubMed ID: 31887288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys.
    Huang LZ; Parameswaran N; Bordia T; Michael McIntosh J; Quik M
    J Neurochem; 2009 May; 109(3):826-37. PubMed ID: 19250334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential nicotinic receptor expression in monkey basal ganglia: effects of nigrostriatal damage.
    Quik M; Polonskaya Y; McIntosh JM; Kulak JM
    Neuroscience; 2002; 112(3):619-30. PubMed ID: 12074903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nicotine and Nicotinic Receptor Drugs: Potential for Parkinson's Disease and Drug-Induced Movement Disorders.
    Quik M; Bordia T; Zhang D; Perez XA
    Int Rev Neurobiol; 2015; 124():247-71. PubMed ID: 26472532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term nicotine treatment decreases striatal alpha 6* nicotinic acetylcholine receptor sites and function in mice.
    Lai A; Parameswaran N; Khwaja M; Whiteaker P; Lindstrom JM; Fan H; McIntosh JM; Grady SR; Quik M
    Mol Pharmacol; 2005 May; 67(5):1639-47. PubMed ID: 15681595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha7 nicotinic receptors as therapeutic targets for Parkinson's disease.
    Quik M; Zhang D; McGregor M; Bordia T
    Biochem Pharmacol; 2015 Oct; 97(4):399-407. PubMed ID: 26093062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of nicotinic acetylcholine receptors that modulate nicotine-evoked [3H]norepinephrine release from mouse hippocampal synaptosomes.
    Azam L; McIntosh JM
    Mol Pharmacol; 2006 Sep; 70(3):967-76. PubMed ID: 16735605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. α-Conotoxin BuIA[T5A;P6O]: a novel ligand that discriminates between α6ß4 and α6ß2 nicotinic acetylcholine receptors and blocks nicotine-stimulated norepinephrine release.
    Azam L; Maskos U; Changeux JP; Dowell CD; Christensen S; De Biasi M; McIntosh JM
    FASEB J; 2010 Dec; 24(12):5113-23. PubMed ID: 20739611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. α7 nicotinic acetylcholine receptor mediated neuroprotection in Parkinson's disease.
    Kawamata J; Suzuki S; Shimohama S
    Curr Drug Targets; 2012 May; 13(5):623-30. PubMed ID: 22300030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role for α6 nicotinic receptors in l-dopa-induced dyskinesias in parkinsonian mice.
    Quik M; Park KM; Hrachova M; Mallela A; Huang LZ; McIntosh JM; Grady SR
    Neuropharmacology; 2012 Sep; 63(3):450-9. PubMed ID: 22579614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice.
    Salminen O; Murphy KL; McIntosh JM; Drago J; Marks MJ; Collins AC; Grady SR
    Mol Pharmacol; 2004 Jun; 65(6):1526-35. PubMed ID: 15155845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.
    Quik M; Wonnacott S
    Pharmacol Rev; 2011 Dec; 63(4):938-66. PubMed ID: 21969327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nicotine and nicotinic receptors; relevance to Parkinson's disease.
    Quik M; Kulak JM
    Neurotoxicology; 2002 Oct; 23(4-5):581-94. PubMed ID: 12428730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for a role for α6(∗) nAChRs in l-dopa-induced dyskinesias using Parkinsonian α6(∗) nAChR gain-of-function mice.
    Bordia T; McGregor M; McIntosh JM; Drenan RM; Quik M
    Neuroscience; 2015 Jun; 295():187-97. PubMed ID: 25813704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacology of alpha-conotoxin MII-sensitive subtypes of nicotinic acetylcholine receptors isolated by breeding of null mutant mice.
    Salminen O; Drapeau JA; McIntosh JM; Collins AC; Marks MJ; Grady SR
    Mol Pharmacol; 2007 Jun; 71(6):1563-71. PubMed ID: 17341654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.